Prior Authorization
A cost-control process used by health insurance companies requiring providers to obtain approval before a specific drug or service is covered.
Prior authorization is a utilization management process used by health insurance companies and pharmacy benefit managers (PBMs). It requires healthcare providers to obtain formal approval from an insurer before a specific medical service, procedure, or prescription drug is cleared for coverage. The process is designed to verify that the requested treatment is medically necessary, cost-effective, and aligned with established clinical guidelines. From an investment perspective, prior authorization is a critical operational lever that directly impacts the financial performance of healthcare companies. For managed care organizations (health insurers), strict authorization protocols help control medical claims expenses and protect underwriting margins. Conversely, for pharmaceutical and medical device manufacturers, these requirements act as administrative hurdles that can delay or restrict patient access, directly limiting product adoption and revenue growth. Investors analyze prior authorization trends to gauge regulatory risks and market access. When insurers tighten these rules, it can signal downward pressure on drug volumes and device sales, while a relaxation of rules can accelerate product launches. However, excessive administrative friction can lead to provider backlash, patient dissatisfaction, and regulatory scrutiny, which may introduce compliance risks for insurers.
A biotech company launches a new specialty drug priced at $5,000 per month. If a health insurer places this drug under a strict prior authorization policy, only 20% of prescribed patients successfully navigate the approval process. Out of 1,000 initial prescriptions, only 200 are filled, resulting in monthly revenue of $1,000,000 (200 $5,000). If the insurer removes the prior authorization requirement, the approval rate jumps to 90%, allowing 900 patients to receive the drug and increasing monthly revenue to $4,500,000 (900 $5,000).